Geneos Wealth Management’s First Trust Active Factor Mid Cap ETF AFMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.94M Sell
82,750
-4,767
-5% -$173K 0.07% 296
2025
Q4
$3.02M Buy
87,517
+2,235
+3% +$76.2K 0.07% 291
2025
Q3
$2.93M Buy
85,282
+80,632
+1,734% +$2.67M 0.07% 285
2025
Q2
$149K Sell
4,650
-3,024
-39% -$92.5K ﹤0.01% 1104
2025
Q1
$234K Buy
+7,674
New +$244K ﹤0.01% 1163

Other funds holding AFMC

Geneos Wealth Management's AFMC Position: Q1 2026 in Review

Geneos Wealth Management reduced its First Trust Active Factor Mid Cap ETF (AFMC) stake by 5.4% in Q1 2026, selling an estimated $173K and leaving 82,750 shares worth $2.94M. The position accounts for 0.07% of the portfolio, ranked #296.

Geneos Wealth Management first reported a position in AFMC in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.02M in Q4 2025. 48 funds tracked by Wall St. Rank hold AFMC as of Q1 2026.

  • Geneos Wealth Management held 82,750 shares of First Trust Active Factor Mid Cap ETF worth $2.94M as of Q1 2026.
  • Geneos Wealth Management sold 4,767 First Trust Active Factor Mid Cap ETF shares in Q1 2026, an estimated $173K.
  • First Trust Active Factor Mid Cap ETF made up 0.07% of Geneos Wealth Management's portfolio in Q1 2026, its #296 holding.
  • Geneos Wealth Management first reported a position in First Trust Active Factor Mid Cap ETF in Q1 2025 and has held it in 5 quarters since.
  • Geneos Wealth Management's First Trust Active Factor Mid Cap ETF position peaked at $3.02M in Q4 2025.
  • 48 funds tracked by Wall St. Rank held First Trust Active Factor Mid Cap ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.